Published in Transplantation on May 27, 1996
Serum levels of alpha1-antitrypsin predict phenotypic expression of the alpha1-antitrypsin gene. Dig Dis Sci (2003) 0.80
[Alpha1-antitrypsin deficiency]. Internist (Berl) (2010) 0.77
Early recognition of alpha-1 antitrypsin deficiency and considerations for liver transplantation. Gastroenterol Hepatol (N Y) (2013) 0.75
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29
Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet (1979) 6.10
Diagnostic importance of changes in circulating concentrations of immunoreactive trypsin. Lancet (1977) 3.43
Good clinical outcomes following transjugular intrahepatic portosystemic stent-shunts in Budd-Chiari syndrome. Aliment Pharmacol Ther (2014) 3.39
Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology (1996) 2.99
Use of partial cardiopulmonary bypass during the anhepatic phase of orthotopic liver grafting. Lancet (1979) 2.98
Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation (2000) 2.90
The frequency and outcome of biliary atresia in the UK and Ireland. Lancet (2000) 2.78
Cyclosporin A in cadaveric organ transplantation. Br Med J (Clin Res Ed) (1981) 2.67
Cholangiography in the jaundiced patient. Gut (1976) 2.44
Medical evacuation from Mostar. Lancet (1996) 2.37
A randomized trial of percutaneous transhepatic cholangiography with the Chiba needle versus endoscopic retrograde cholangiography for bile duct visualization in jaundice. Gastroenterology (1976) 2.25
Selective decontamination of the digestive tract reduces gram-negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Crit Care Med (1994) 2.21
Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient. Gut (2000) 2.16
Serum trypsin concentrations in diabetes mellitus. Br Med J (1978) 2.09
Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. BMJ (1996) 2.04
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99
Cyclosporin A: preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants. Transplant Proc (1979) 1.94
Arginine-16 beta2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol. Thorax (2006) 1.86
Human hepatic stem-like cells isolated using c-kit or CD34 can differentiate into biliary epithelium. Gastroenterology (2001) 1.83
Clinical spectrum, investigations and treatment of Budd-Chiari syndrome. QJM (1996) 1.81
Bile duct injury following laparoscopic cholecystectomy: referral pattern and management. Br J Surg (1997) 1.81
Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut (1999) 1.80
Acute polymyositis in an adult associated with Mycoplasma pneumoniae infection. Postgrad Med J (1990) 1.80
The slowing of gastric emptying by monosaccharides and disaccharides in test meals. J Physiol (1968) 1.79
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet (1996) 1.78
Neurological complications following liver transplantation. Lancet (1987) 1.76
Wilson's disease with superimposed autoimmune features: report of two cases and review. J Gastroenterol Hepatol (2000) 1.70
Native and recombinant human hepatocyte growth factors are highly potent promoters of DNA synthesis in both human and rat hepatocytes. J Clin Invest (1991) 1.70
Paracetamol induced hepatotoxicity. Arch Dis Child (2006) 1.67
Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. Gut (1997) 1.66
Delay in presentation of symptomatic referrals to a breast clinic: patient and system factors. Br J Cancer (2000) 1.66
Liver resection for colorectal metastases. Ann R Coll Surg Engl (2003) 1.66
Identification of serum biomarkers for colon cancer by proteomic analysis. Br J Cancer (2006) 1.66
Treatment of hydatid disease of the liver. Evaluation of a UK experience. Dig Surg (2004) 1.65
Clinical heterogeneity associated with deletions in the long arm of chromosome 15: report of 3 new cases and their possible genetic significance. Am J Med Genet (1987) 1.62
ECG and echocardiographic diagnosis of pulmonary thromboembolism associated with central venous lines. Arch Dis Child (1995) 1.58
Radiological intervention in Budd-Chiari syndrome: techniques and outcome in 18 patients. Clin Radiol (1996) 1.57
Sulphoxidation and sulphation capacity in patients with primary biliary cirrhosis. J Hepatol (1995) 1.54
Recovery despite impaired cerebral perfusion in fulminant hepatic failure. Lancet (1994) 1.53
Observations on preservation, bile drainage and rejection in 64 human orthotopic liver allografts. Ann Surg (1977) 1.53
Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients. Br J Cancer (2007) 1.52
Chronic pancreatitis: a cause of cholestasis. Gut (1977) 1.51
Chronic renal failure following liver transplantation: a retrospective analysis. Transplantation (1998) 1.49
Combined liver-kidney transplantation for primary hyperoxaluria type 1 in young children. Nephrol Dial Transplant (2001) 1.47
MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease). Hepatology (2001) 1.47
Enhanced (cytomegalovirus) viral replication after transplantation for fulminant hepatic failure. Liver Transpl Surg (1997) 1.44
Pancreatic cholera due to production of gastric inhibitory polypeptide. Lancet (1972) 1.44
Isolated liver transplant in infants with short bowel syndrome: insights into outcomes and prognostic factors. J Pediatr Gastroenterol Nutr (2009) 1.42
Retrospective study of acute toxicity following short-course preoperative radiotherapy. Br J Surg (2002) 1.42
Association of spinocerebellar disorders with cystic fibrosis or chronic childhood cholestasis and very low serum vitamin E. Lancet (1981) 1.40
Colonic Crohn's disease and use of oral contraception. Br Med J (Clin Res Ed) (1984) 1.40
Cerebral aspergillosis in liver transplantation. J Clin Pathol (1990) 1.40
Successful pregnancy in a patient with type III glycogen storage disease managed with cornstarch supplements. Br J Obstet Gynaecol (1998) 1.40
Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet (2000) 1.39
Serum lipids and apolipoproteins in liver transplant recipients: a comparative study of cyclosporin A and FK 506. J Lab Clin Med (1994) 1.39
Prolongation of canine pancreas allograft survival with cyclosporin A: preliminary report. Br Med J (1980) 1.38
Primary hepatic malignancy: the role of liver transplantation. Br J Surg (1990) 1.34
Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor-infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma. J Immunol (1998) 1.33
Fulminant hepatitis B in infants born to anti-HBe hepatitis B carrier mothers. BMJ (1992) 1.32
Consensus document: therapeutic monitoring of tacrolimus (FK-506). Ther Drug Monit (1995) 1.30
GSTM1 null polymorphism at the glutathione S-transferase M1 locus: phenotype and genotype studies in patients with primary biliary cirrhosis. Gut (1993) 1.30
Increased severity and morbidity of acute hepatitis in drug abusers with simultaneously acquired hepatitis B and hepatitis D virus infections. Br Med J (Clin Res Ed) (1985) 1.29
Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature. J Hepatol (2004) 1.28
Expression of the stem cell factor receptor c-kit in normal and diseased pediatric liver: identification of a human hepatic progenitor cell? Hepatology (1999) 1.28
Hypercatabolism of the third component of complement in patients with primary biliary cirrhosis. J Lab Clin Med (1976) 1.27
Poor prognosis and limited therapeutic options in patients with Budd-Chiari syndrome and portal venous system thrombosis. Eur J Gastroenterol Hepatol (1997) 1.24
Biopsy findings in cases of rejection of liver allograft. J Clin Pathol (1985) 1.24
Modulation of iron transport proteins in human colorectal carcinogenesis. Gut (2006) 1.23
Stress fracture of the first rib. Am J Orthop (1966) 1.22
Frequency and impact of extracolonic findings detected at computed tomographic colonography in a symptomatic population. Br J Surg (2007) 1.22
Endoscopic retrograde cholangiopancreatography in the diagnosis of jaundice associated with ulcerative colitis. Gastroenterology (1974) 1.22
The treatment of major liver trauma by primary packing with transfer of the patient for definitive treatment. Br J Surg (1979) 1.20
Seamless management of biliary atresia in England and Wales (1999-2002). Lancet (2004) 1.19
Massive hepatic fibrosis in Gaucher's disease: clinico-pathological and radiological features. QJM (2000) 1.18
Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours. Br J Cancer (1987) 1.18
Sclerosing cholangitis associated with multifocal fibrosis: a case report. Gut (1992) 1.17
High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation. J Hepatol (1999) 1.17
Transplantation of the liver in adults and children with fulminant hepatic failure. J Hepatol (1988) 1.16
Cyclosporin-A in clinical organ grafting. Transplant Proc (1981) 1.16
Left-sided gall bladder: a diagnostic and surgical challenge. ANZ J Surg (2001) 1.16
Recurrence of autoimmune hepatitis after liver transplantation. Transplantation (1999) 1.16
Transforming growth factor-beta induces human T lymphocyte migration in vitro. J Immunol (1991) 1.15
Combination alpha-interferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection: results of a pilot study. J Hepatol (1998) 1.14
The development of biliary "sludge" following liver transplantation. Transplant Proc (1979) 1.14
Successful liver transplantation in babies under 1 year. BMJ (1993) 1.14
The challenges and opportunities for transitional care research. Pediatr Transplant (2010) 1.14
Phalloidin-induced cholestasis: a microfilament-mediated change in junctional complex permeability. Proc Natl Acad Sci U S A (1980) 1.13